{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:50:24Z","timestamp":1793767824423,"version":"4.6.1"},"reference-count":22,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T00:00:00Z","timestamp":1169424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Rifaximin is a broad spectrum non\u2010absorbable antibiotic used for treatment of small intestinal bacterial overgrowth. Doses of 1200\u2003mg\/day showed a decontamination rate of 60% with low side\u2010effects incidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To assess efficacy, safety and tolerability of rifaximin 1600\u2003mg with respect to 1200\u2003mg\/day for small intestinal bacterial overgrowth treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eighty consecutive small intestinal bacterial overgrowth patients were enrolled. Diagnosis of small intestinal bacterial overgrowth based the clinical history and positivity to H<jats:sub>2<\/jats:sub>\/CH<jats:sub>4<\/jats:sub> glucose breath test. Patients were randomized in two 7\u2010day treatment groups: rifaximin 1600\u2003mg (group 1); rifaximin 1200\u2003mg (group 2). Glucose breath test was reassessed 1\u2003month after. Compliance and side\u2010effect incidence were also evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One drop\u2010out was observed in group 1 and two in group 2. Glucose breath test normalization rate was significantly higher in group 1 with respect to group 2 both in intention\u2010to\u2010treat (80% vs. 58%; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) and per protocol analysis (82% vs. 61%; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). No significant differences in patient compliance and incidence of side effects were found between groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Rifaximin 1600\u2003mg\/day showed a significantly higher efficacy for small intestinal bacterial overgrowth treatment with respect to 1200\u2003mg with similar compliance and side\u2010effect profile.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2007.03259.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T10:46:56Z","timestamp":1279882016000},"page":"781-786","source":"Crossref","is-referenced-by-count":91,"title":["High dosage rifaximin for the treatment of small intestinal bacterial overgrowth"],"prefix":"10.1111","volume":"25","author":[{"given":"E.","family":"SCARPELLINI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"GABRIELLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"LAURITANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"LUPASCU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"MERRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"CAMMAROTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. A.","family":"CAZZATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"GASBARRINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"GASBARRINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,22]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"19","volume":"7","author":"Singh VV","year":"2004","journal-title":"Small bowel bacterial overgrowth: presentation, diagnosis, and treatment"},{"key":"e_1_2_6_3_2","first-page":"412","article-title":"Normalization lactulose breath test correlates with symptom improvement in irritable bowel syndrome: a double\u2010blind, randomized, placebo\u2010controlled study","volume":"98","author":"Pimentel M","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03368.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02690.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05664.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90173-4"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0016-5085(90)91339-8","article-title":"Glucose\u2010H2 breath test for small intestinal bacterial overgrowth","volume":"98","author":"Kerlin P","year":"1990","journal-title":"Gastroenterology"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90818-L"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000089776"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000089778"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2006.03.008"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666030-00003"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000081999"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-10-200505170-00005"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02516.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33741"},{"key":"e_1_2_6_18_2","first-page":"695","article-title":"The possible role of breath methane measurement in detecting carbohydrate malabsorption","volume":"124","author":"Corazza GR","year":"1994","journal-title":"J Lab Clin Med"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-005-0025-x"},{"key":"e_1_2_6_20_2","first-page":"19","article-title":"Rifaximin: a nonabsorbed oral antibiotic","volume":"5","author":"Baker DE","year":"2005","journal-title":"Rev Gastroenterol Disord"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00751.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i18.2773"},{"key":"e_1_2_6_23_2","first-page":"89","article-title":"Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin","volume":"52","author":"Cuoco L","year":"2006","journal-title":"Minerva Gastroenterol Dietol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2007.03259.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2007.03259.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:30:46Z","timestamp":1697232646000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2007.03259.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,22]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1365-2036.2007.03259.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03259.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,22]]}}}